The [64Cu]Cu-DO3A-VS-M5A∆CH2-C5 PET imaging demonstrated high tumor targeting and favorable pharmacokinetics in two CEA-positive colorectal cancer mouse models. The gene discussed is CEACAM5; the disease is colorectal cancer.